White Paper | Analytical Approaches for Identification and Quantification of Impurities in Pharmaceutical Products

One of the most important quality-relevant parameters of pharmaceuticals is the purity of a product. Across the sector, the highest efforts are made to reduce the risks of contamination of the product and each pharmaceutical is therefore checked for purity before being placed on the market. This is a fundamental part of every quality control process.

Next to quality control, organoleptical reasons may stimulate investigations into the purity of a product. Changes in odour, colour, taste, or the appearance of visible particles - often noticed by health care personnel or patients - may be an indicator of product quality defects caused by impurities.

In this white paper our expert, Tino Otte, Head of Sales and Consulting, examines sources of impurities in drug products and describes the analytical techniques required to identify and quantify impurities.

Complete the form below to access the white paper.